What’s needed for a strong regulatory system in Africa
About IFPMA
IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.
ifpma.org
To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.
Related news and resources
AMATA statement at 75th WHO AFRO: Progress report on the regional strategy on regulation of medical products in African region
On 27 August 2025, the African Medicines Agency Treaty Alliance submitted a statement on agenda item 16.8: Progress report on the regional strategy on regulation of medical products in African region, 2016-2025 at the 75th Session of the WHO Regional Committee for Africa. The African Medicines Agency Treaty Alliance (AMATA) commends the progress made under...
Read more75th WHO Regional Committee for Africa: Progress report on the implementation of the strategy for scaling up health innovations in the African region
On 27 August 2025 in Lusaka, Zambia, IFPMA delivered a statement at the 75th session of the WHO Regional Committee for Africa focused on Agenda item 16.2: Progress report on the implementation of the strategy for scaling up health innovations in the African region. IFPMA takes note of WHO AFRO’s Progress report on the implementation...
Read moreStreamlining samples management to strengthen health outcomes in Africa
Ensuring the quality, safety, and efficacy of pharmaceutical products is a cornerstone of public health. To meet these high standards, innovative multinational pharmaceutical companies perform rigorous batch release testing for every product, following internationally recognized protocols and approved specifications. However, countries may require additional in-country testing by their National Regulatory Authorities (NRAs) or National Control...
Read more